Clinical and Economic Burden of Illness in Patients with Persistent or Chronic Primary Immune Thrombocytopenia Treated with TPO-Ras and RituximabDavid J. Kuter, Natalia Petruski‐Ivleva, Matias Cordoba et al.|Blood|2023Cited by 2
First-Time Users of Advanced Therapies Among Adult Patients with Persistent or Chronic Primary Immune Thrombocytopenia: Patient Characteristics, Treatment Switching Patterns, and Clinical OutcomesDavid J. Kuter, Natalia Petruski‐Ivleva, Duane Madziva et al.|Blood|2023Cited by 0
Clinical Burden of Illness in Patients with Persistent or Chronic Primary Immune Thrombocytopenia Treated with Advanced Therapies in the United StatesDavid J. Kuter, Natalia Petruski‐Ivleva, Imène Gouia et al.|Blood|2024Cited by 0